Date
- Monday, 23 June 2014, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
This event aims to promote communication between national competent authorities and patient and healthcare-professional organisations, providing an overview on the latest norms and guidelines on clinical trials and an introduction to the pharmacovigilance legislation. It aims to serve also as a platform for networking between local organisations and authorities in order to promote further activities and cooperation. It is supported by the European Commission and organised in collaboration with the Medicines and Medical Devices Agency of Serbia as a final event prior the closure of the Instrument for Pre-accession I Programme.Registration by invitation only.